Metformin upregulates hENT1 expression and enhances gemcitabine efficacy in pancreatic cancer cells

被引:2
|
作者
Joseph, Stancy J. [1 ]
Osborne, Taylor [1 ]
Word, Beverly [1 ]
Lyn-Cook, Beverly [1 ]
机构
[1] US FDA, NCTR, Jefferson, AR USA
关键词
D O I
10.1158/1538-7445.AM2015-4436
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4436
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Determination of hENT1 expression by a novel rabbit monoclonal antibody immunohistochemistry test for pancreatic cancer
    Boeck, S.
    Raponi, M.
    Richardson, B.
    Towne, P.
    Isaacson, J.
    Ranger-Moore, J.
    Clements, J.
    Rolfe, L.
    Ormanns, S.
    Kirchner, T.
    Regine, W. F.
    Andersson, R.
    Dicker, A. P.
    Ikdahl, T.
    Poplin, E. A.
    Heinemann, V.
    ONKOLOGIE, 2012, 35 : 51 - 51
  • [22] HENT1 AND DCK EXPRESSION PREDICT BENEFIT FROM GEMCITABINE AFTER CURATIVE-INTENT RESECTION IN PANCREATIC ADENOCARCINOMA
    Marechal, Raphael
    Bachet, Jean-Baptiste
    Mackey, John R.
    Demetter, Pieter
    Graham, Kathryn
    Couvelard, Anne
    Svrcek, Magali
    Bardier-Dupas, Armelle
    Hammel, Pascal
    Sauvanet, Alain
    Louvet, Christophe
    Paye, Francois
    Rougier, Philippe
    Hannoun, Laurent
    Andre, Thierry
    Cass, Carol E.
    Salmon, Isabelle
    Emile, Jean-Francois
    Van Laethem, Jean-Luc
    ANNALS OF ONCOLOGY, 2011, 22 : v12 - v12
  • [23] Human equilibrative nucleoside transporter 1 (hENT1) expression as a predictive biomarker for gemcitabine chemotherapy in biliary tract cancer
    Kim, Jaihwan
    Kim, Haeryoung
    Lee, Jong-Chan
    Kim, Jin Won
    Paik, Woo Hyun
    Lee, Sang Hyub
    Hwang, Jin-Hyeok
    Ryu, Ji Kon
    Kim, Yong-Tae
    PLOS ONE, 2018, 13 (12):
  • [24] Gemcitabine versus FOLFIRINOX in patients with advanced pancreatic adenocarcinoma HENT1 positive: back to the future
    Calegari, M. A.
    Orlandi, A.
    Cocomazzi, A.
    Martini, M.
    Bagala, C.
    Indellicati, G.
    Zurlo, V.
    Monterisi, S.
    Di Dio, C.
    Barile, R.
    Di Salvatore, M. A.
    Basso, M.
    Cassano, A.
    Larocca, L. M.
    Barone, C.
    ANNALS OF ONCOLOGY, 2015, 26
  • [25] Roles for hENT1 and dCK in gemcitabine sensitivity and malignancy of meningioma
    Yamamoto, Masahiro
    Sanomachi, Tomomi
    Suzuki, Shuhei
    Uchida, Hiroyuki
    Okada, Masashi
    Sonoda, Yukihiko
    Yoshimoto, Koji
    Kitanaka, Chifumi
    CANCER SCIENCE, 2022, 113 : 1472 - 1472
  • [26] hENT1 testing in pancreatic ductal adenocarcinoma: Are we ready yet? A multimodal evaluation of hENT1 status
    Cros, J.
    Marechal, R.
    Bachet, J. B.
    Puleo, F.
    Laurent-Puig, P.
    Bedossa, P.
    Flejou, J. F.
    Demetter, P.
    Svrcek, M.
    VIRCHOWS ARCHIV, 2015, 467 : S7 - S7
  • [27] Roles for hENT1 and dCK in gemcitabine sensitivity and malignancy of meningioma
    Yamamoto, Masahiro
    Sanomachi, Tomomi
    Suzuki, Shuhei
    Uchida, Hiroyuki
    Yonezawa, Hajime
    Higa, Nayuta
    Takajo, Tomoko
    Yamada, Yuki
    Sugai, Asuka
    Togashi, Keita
    Seino, Shizuka
    Okada, Masashi
    Sonoda, Yukihiko
    Hirano, Hirofumi
    Yoshimoto, Koji
    Kitanaka, Chifumi
    NEURO-ONCOLOGY, 2021, 23 (06) : 945 - 954
  • [28] Human Equilibrative Transporter 1 (hENT1) Expression is not Predictive for Gemcitabine Outcome in Patients With Advanced Biliary Tract Cancer
    Son, Jun Hyuk
    Jang, Dong Kee
    Lee, Jae Woo
    Park, Jin Myung
    Lee, Sang Hyub
    Ahn, Dong-Won
    Ryu, Ji Kon
    Kim, Yong-Tae
    GASTROENTEROLOGY, 2016, 150 (04) : S515 - S515
  • [29] hENT1's role in adjuvant intra-arterial gemcitabine-based chemotherapy for resectable pancreatic cancer patients
    Wang, Wei
    Yu, Xinzhe
    Li, Hengchao
    Yang, Chuanxin
    Jin, Chen
    Huang, Xinyu
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [30] hENT1 RNA and Protein in Combination May Act as Predictive Biomarkers for Survival for Patients Treated With Adjuvant Gemcitabine in Pancreatic Cancer
    Hale, J.
    Evans, A.
    Aughton, K.
    Elander, N. O.
    Ghaneh, P.
    Neoptolemos, J. P.
    Jackson, R.
    Cox, T. F.
    Campbell, F.
    Halloran, C. M.
    Mackey, J. R.
    Scarfe, A. G.
    Valle, J. W.
    Carter, R.
    Cunningham, D.
    Tebbutt, N. C.
    Goldstein, D.
    Shannon, J.
    Glimelius, B.
    Deakin, M.
    Charnley, R. M.
    Anthoney, A.
    Lerch, M. M.
    Mayerle, J.
    Costello, E.
    Palmer, D. H.
    Buechler, M. W.
    Greenhalf, W.
    PANCREAS, 2019, 48 (10) : 1436 - 1437